Join
Live feed
·
INSIDERFilingvia Quantisnow
Lisata Therapeutics Inc. logo

President & CEO Mazzo David J was granted 81,000 shares and covered exercise/tax liability with 30,462 shares, increasing direct ownership by 24% to 264,690 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
LSTA· Lisata Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track LSTA (Lisata Therapeutics Inc.) and more on Quantisnow.